Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment

Overview of attention for article published in Journal of Clinical Oncology, April 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 21 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 19 Mendeley

So far, Altmetric has seen 22 X posts from 21 X users, with an upper bound of 20,047 followers.

Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment | Journal of Clinical Oncology https://t.co/ncOdCrxYUX

New Publication, "Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment" by Nayan Lamba, Helen A Shih, Rifaquat Rahman, et al. #MGBCTNS Read here: https://t.c…

Melanoma patients with brain metastases now enjoy improved survival outcomes thanks to updated prognostic factors and individualized treatment strategies. by Sperduto PW, Marqueen KE (...) Mehta MP et 38 al. in J Clin Oncol https://t.co/Ls9cCLqKa0 #Med…

#J_Clin_Oncol IF:42.1 Retrospective study (n=1,796) showed updated Melanoma GPA for metastatic melanoma brain metastases improved prognostication, with median survival 16.6 months (vs 9.8 in prior cohort). PMID:40245362 https://t.co/9BRRaC9XTF

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 18 additional X posts.